Tumor-Induced Immune Suppression Mechanisms and Therapeutic Reversal /
| Autor Corporativo: | |
|---|---|
| Otros Autores: | , |
| Formato: | eBook |
| Lenguaje: | English |
| Publicado: |
New York, NY :
Springer New York : Imprint: Springer,
2008.
|
| Edición: | 1st ed. 2008. |
| Materias: | |
| Acceso en línea: | https://doi.org/10.1007/978-0-387-69118-3 |
Tabla de Contenidos:
- Immune-Suppressive Mechanisms and Cancer: Understanding the Implications, Paradoxes, and Burning Questions
- Mechanisms of Tumor-Associated T-Cell Tolerance
- Contribution of B7-H1/PD-1 Co-inhibitory Pathway to T-Cell Dysfunction in Cancer
- Regulatory T Cells in Cancer
- Cancer-Induced Signaling Defects in Antitumor T Cells
- Immunobiology of Dendritic Cells in Cancer
- Macrophages and Tumor Development
- Myeloid-Derived Suppressor Cells in Cancer
- Signaling Pathways in Antigen-Presenting Cells Involved in the Induction of Antigen-Specific T-Cell Tolerance
- Arginine Availability Regulates T-Cell Function in Cancer
- Protein–Glycan Interactions in the Regulation of Immune Cell Function in Cancer: Lessons from the Study of Galectins-1 and -3
- Role of Reactive Oxygen Species in T-Cell Defects in Cancer
- Tumor Stroma and the Antitumor Immune Response.